Blood phosphorylated tau as biomarkers for Alzheimer’s diseaseThomas K. Karikari · University of Gothenburg10 Dec
A behavioural assessment to characterize different stages of memory impairment in humanized APP knock-in mouse models across various agesLoukia Katsouri, Angela Misak, Stephen Burton et al.
The brain-gut axis in Alzheimer’s disease: Insights into a new clearance mechanism of amyloid beta peptide and tau proteinMaxime Seignobos, Sylvie Boisseau, Frédérique Vossier et al.
Brain slice derived nerve fibers grow along microcontact prints and are stimulated by beta-amyloid(42)Katharina Steiner, Christian Humpelvia tau neurofibrillary tangles
Characterization of the biological effect of new molecules as potential therapeutic agents for Alzheimer's diseasePatricia Llanes Fernández, Ricardo Márquez, Diego Samper et al.
Early onset of tau pathology in the olfactory system of PS19 mice: A pathway for the progression of tauopathy in the central nervous systemMarion Dourte, Pascal Kienlen-Campard, Florence Chainiaux-Debacq et al.
Early tau pathology accumulation in postmortem Default Mode network hubsBetul Kara, Tessa Grabinski, Nicholas Kanaan et al.
Genetic deletion of astrocytic calcineurin B1 prevents cognitive impairment and neuropathology development in acute and chronic mouse models of Alzheimer’s diseaseGiulia Dematteis, Laura Tapella, Gianluigi Forloni et al.
Investigating a new tau aggregation inhibitor “RE01” in PS19 transgenic miceDilek Mercan, Arush Baijal, Fabrizio Musacchio et al.
Investigating the role of hyperphosphorylated tau in both neurodegenerative disease and glioblastoma using adult human organotypic slice culturesConnie MacKenzie-Gray Scott, David Koss, Lauren O'Neill et al.
Longitudinal assessment of neurodegeneration in a mouse model of tauopathy using multiparametric magnetic resonance imagingAnnacarla Martucci, Franca Orsini, Edoardo Micotti et al.
Modulation of release of amyloid-β in live human brain slice culturesSoraya Meftah, Robert McGeachan, Lewis Taylor et al.
The novel astrocytic marker CETN2 expression in Alzheimer’s diseaseMaria Teresa Dell'Anno, Elisa Degl'Innocenti, Francesco Olimpico et al.
Protective effect of growth hormone-releasing hormone (GHRH) agonist MR-409 in Alzheimer’s diseaseGiulia Morello, Francesca Pedrolli, Iacopo Gesmundo et al.via tau neurofibrillary tangles
Retinal and behavioral characterization of a streptozotocin-induced diabetes type 2 model in the search of early symptoms of Alzheimer’s diseaseGeorg Ladurner, Daurer Magdalena, Roland Rabl et al.
Selective detection of neurofibrillary tangles (NFTs) in iPSC-derived retinal cells and postmortem samples of Alzheimer's disease patients’ retina by a novel BODIPY-fluorescent ligandYlenia Gigante
Tau spreading in Alzheimer’s disease models is facilitated by the amyloid-β precursor proteinMagdalena Przybyla, Janet van Eersel, Sian Genoud et al.
Synergistic effects of α-synuclein, tau, and amyloid pathology on mitophagy in dementia with Lewy bodiesWolfdieter Springer, Xu Hou, Tyrique Richardson et al.
Therapeutic potential of neurosteroids DHEA and DHEAS in mouse models of Alzheimer’s diseaseBarbara Vuić, Tina Miloš, Vladimir Farkaš et al.